NCT00152412View on ClinicalTrials.gov

Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Allergic Rhinitis
Interventions
DRUG

Levocetirizine oral solution

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY